INSMED Inc
Company Stats
- Market Cap
- $24.9B
- as of Sep 30, 2026
- Shares Outstanding
- 218.4M
- Free Float
- 93.7%
Income Statement
- Revenue
- $606.4M
- Operating Income
- -$1.2B
- Net Income
- -$1.3B
- EBITDA
- -$1.2B
- Revenue Growth, 3Y
- 35.2%
- FCF Margin, 3Y Avg
- -177.9%
- FCF Margin, Worst Year
- -194.1%
Cash Flow
- Free Cash Flow
- -$967.6M
- FCF Yield
- -3.9%
- Owner FCF Yield
- -4.5%
Balance Sheet
- Cash & Equivalents
- $510.4M
Returns & Capital
- SBC, 3Y Avg
- $108.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $606.4M | -$967.6M | -159.6% |
| FY2024 | $363.7M | -$705.8M | -194.1% |
| FY2023 | $305.2M | -$549.5M | -180.1% |
| FY2022 | $245.4M | -$410.3M | -167.2% |
| FY2021 | $188.5M | -$370.6M | -196.6% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 27, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back